-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

651.P1.53 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster I

Symposia: Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Samuel Cutler, BS, MSc1, Amy Trottier, MD, MSc, FRCPC2, Daniel Gaston, PhD3*, Nicholas Allen Forward, MD4, Darrell White5, Alfredo H. De La Torre, MD6 and Manal Elnenaei, MD, PhD, MSc3,7*

1Department of Medicine, Dalhousie University, Wellington, NS, Canada
2Division of Hematology, Department of Medicine, Nova Scotia Health, Halifax, NS, Canada
3Pathology, Dalhousie University, Halifax, NS, Canada
4Queen Elizabeth II Health Sciences Centre, Halifax, Canada
5Dalhousie University and QEII Health Sciences Centre, Halifax, NS, CAN
6QEII Health Sciences Centre, Halifax, NS, CAN
7Clinical Chemistry, Nova Scotia Health Authority, Halifax, NS, CAN

David Fandrei, MSc1,2*, Michael Rade, PhD1*, Markus Kreuz, PhD1*, Luise Fischer, PhD3*, Patrick Born4*, Sabine Seiffert5*, Andreas Boldt, MD5*, Jonathan Scolnick, PhD6*, Lakshmi Venkatraman7*, Stacy Xu, PhD8*, Ronny Baber, PhD9,10*, Song Yau Wang, MD2*, Enrica Bach, PhD2*, Sandra Hoffmann4*, Klaus H Metzeler, MD2, Marco Herling, MD2*, Madlen Jentzsch, MD11*, Georg-Nikolaus Franke, MD4*, Ulrike Köhl, MD, PhD1,5*, Uwe Platzbecker, MD2, Vladan Vucinic, MD12*, Kristin Reiche, PhD1,5,13* and Maximilian Merz, MD2

1Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany
2Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
3Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Saxony, Germany
4Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
5Institute of Clinical Immunology, University of Leipzig Medical Center, Leipzig, Germany
6Singleron Biothechnologies Pte Ltd, Singapore, Singapore
7Singleron Biotechnologies, Singapore, Singapore
8Singleron Biotechnologies Pte LtD, Singapore, Singapore
9Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig Medical Center, Leipzig, Germany
10Medical Biobank, University of Leipzig Medical Center, Leipzig, Germany
11Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Sachsen, Germany
12Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Saxony, Germany
13Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI), Dresden, Leipzig, Germany

Erin Flynt, PhD1*, Chad A. Lewis, PhD2*, Benjamin Winograd, MD, PhD2*, Terry Connolly, PhD2*, Lan Xu, PhD2* and Anil Menon, PhD2*

1K36 Therapeutics, Summit, NJ
2K36 Therapeutics, Cambridge, MA

Carmen Gonzalez, MSc1*, Camila Guerrero, PhD1*, Juan-José Garcés, PhD1*, Alejandro Medina, PhD2*, Noemi Puig, PhD2, Maria Teresa Cedena Romero, MD, PhD3*, Diego Alignani, PhD1*, Sarai Sarvide1*, Paula Aguirre-Ruiz, MSc1*, Jose Maria Lamo-Espinosa, MD1*, Felipe Prosper, MD, PhD1, Paula Rodríguez-Otero, MD, PhD1*, Jose A. Martinez-Climent, MD, PhD1, Aldo Roccaro, MD, PhD4, Antonio Sacco, MSc4*, Mario Nuvolone, MD, PhD5*, Giovanni O. Palladini, MD, PhD5, Laura Rosiñol Dachs, MD PhD6*, Ramon García-Sanz, MD, PhD2, Joaquín Martínez-Lopez3*, Juan-Jose Lahuerta Palacios, MD, PhD3*, Maria-Victoria Mateos, MD, PhD2, Joan Bladé, MD, PhD6*, Jesús F. San-Miguel, MD, PhD1 and Bruno Paiva, PhD1*

1Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBER-ONC, Pamplona, Spain
2Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBER-ONC, Salamanca, Spain
3Hematology Department, Hospital Universitario 12 de Octubre, CIBER-ONC, Instituto de Investigación IMAS12, Madrid, Spain
4ASST Spedali Civili di Brescia, Clinical Trial Center, Translational Research and Phase I Unit, Brescia, Italy
5Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia, Pavia, Italy
6Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain

Cinnie Soekojo, MD1,2, Susan M. Geyer, PhD3, Emmanuel Contreras Guzman1*, Kaitlyn Whitaker, M.S.1*, Shaji Kumar, MD1, Vincent Rajkumar, MD1*, Joselle Cook, MBBS1, Yogesh Chawla, PhD1*, Francis Buadi, MD1, Angela Dispenzieri, MD1, Moritz Binder, MD1, Rafael Fonseca, MD4, Taro Hitosugi5, Dragan Jevremovic, M.D., Ph.D6*, Wilson I. Gonsalves, MD1 and Jose C. Villasboas Bisneto, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2National University Cancer Institute of Singapore, Singapore, Singapore, Singapore
3Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Paradise Valley, AZ
5Department of Oncology, Mayo Clinic, Rochester, MN
6Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Bo Hu1*, Hardik Modi1*, Diana Jankeel2*, Jacob T. Edwards3*, Junfei Zhao4*, Chad C. Bjorklund4*, Gaurav Jain5*, Patrick R. Hagner, PhD4*, Maria Ortiz6*, Zhongying Mo1*, Celia Fontanillo1*, Christoph W. Zapf2*, Antonia Lopez-Girona2*, Neil Bence2*, Kai Wang1*, Anita K. Gandhi, PhD7, Mark Rolfe2, Deborah S. Mortensen2* and Lynda Groocock2*

1Bristol Myers Squibb, San Diego, CA
2Research and Development, Bristol Myers Squibb, San Diego, CA
3Bristol Myers Squibb, Redwood City, CA
4Bristol Myers Squibb, Summit, NJ
5Bristol Myers Squibb, Bangalore, India
6Bristol Myers Squibb, Seville, Spain
7Hematology, Translational Medicine, Bristol Myers Squibb, Summit, NJ

Nathan Becker, MS1*, Enze Liu, PhD2*, Parvathi Sudha, MS2*, Riya Sharma, MS2*, Travis Johnson, PhD3, Aneta Mikulasova, PhD4*, Rafat Abonour, MD2 and Brian A. Walker, PhD2

1Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Fishers, IN
2Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN
3Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN
4Centre for Cancer and Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom

Lifang Zou1* and Fei Li2

1Department of Hematology,Jiangxi Clinical Research Center for Hematologic Disease,Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China, Nanchang, CA, China
2Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China;, Nanchang, China

Takeshi Harada, MD, PhD1, Yusuke Inoue, PhD2*, Asuka Oda1*, Jumpei Teramachi3*, Yusaku Maeda1*, Ryohei Sumitani1*, Masahiro Oura1*, Kimiko Sogabe1*, Hikaru Yagi1*, Shiro Fujii1*, Shingen Nakamura4*, Hirokazu Miki5*, Kumiko Kagawa, MD, PhD6*, Shuji Ozaki6, Ken-ichi Matsuoka, MD, PhD1* and Masahiro Abe7*

1Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
2Department of Medical Technology, Tokushima University Hospital, Tokushima, Japan
3Department of Oral Function and Anatomy, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JPN
4Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, Tokushima, Japan
5Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan
6Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan
7Department of Hematology, Kawashima Hospital, Tokushima, Japan, Tokushima, Japan

Visanu Wanchai, PhD1*, Hongwei Xu, DDS2*, Cody Ashby, PhD1*, Frits van Rhee, MD, PhD2, Guido Tricot, MD2*, John D Shaughnessy, Jr, PhD2* and Fenghuang Zhan, MD2

1Department of Bioinformatics, University of Arkansas for Medical Sciences, Little Rock, AR
2Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Xiangao Huang, PhD1*, David S Jayabalan, MSc1*, Maurizio Di Liberto, PhD1*, Zhengming Chen, PhD1*, Scott Ely, MD1, Roger Pearse, MD, PhD1*, Joseph Lane, MD2*, Gang Lin, PhD1*, Ruben Niesvizky, MD3 and Selina Chen-Kiang, PhD1

1Weill Cornell Medicine, New York, NY
2Hospital For Special Surgery, New York, NY
3Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY

David Zihala1,2*, Anjana Anilkumar Sithara3,4,5*, Veronika Kapustova4,5*, Ondrej Venglar4,5*, Eva Radova4,5*, Lucie Broskevicova4,5*, Jan Vrana4,5*, Serafim Nenarokov4,5*, Daniel Bilek3*, Ludmila Muronova1,2*, Tereza Popkova, MD1,2*, Jana Mihalyova4,5*, Hana Plonkova, MD2*, Sandra Charvatova4,5*, Kamlesh Bisht6*, Hongfang Wang, PhD6*, Helgi Van de Velde, MD, PhD6, Michal Simicek4,5*, Tereza Sevcikova5,7*, Roman Hajek, MD, PhD5,8 and Tomas Jelinek5,9

1Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
2Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
3Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic
4Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
5Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
6Sanofi R&D, North America, Cambridge, MA
7Department of Hematooncology, University Hospital Ostrava, Ostrava, AL, Czech Republic
8University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic
9Department of Hematooncology, University Hospital Ostrava, Ostrava, Ostrava-Mesto, Czech Republic

Rena Feinman, PhD1, Ariel Aptekmann, PhD1*, Iriana Colorado, MSc1*, Reilly Kobbe, BSc1*, Marta Salas, BSc1*, Noa Biran, MD2, David S. Siegel, MD, PhD1,3 and Benjamin Tycko, MD, PhD1*

1Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ
2Division of Multiple Myeloma, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
3John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ

Aleksandra Kurowska1*, Azari Bantan2*, Raghad Shuwaikan3*, Itziar Cenzano, PhD1*, Paula Aguirre-Ruiz, MSc4*, Estíbaliz Miranda4*, Leire Garate4*, Amaia Vilas-Zornoza4*, Patxi San-Martin4*, Marta Larrayoz, PhD4*, Nahia Gómez-Echarte4*, Beñat Ariceta4,5*, Daniel Soto Ortiz1*, Turki Sobahy2*, José Ignacio Martín-Subero6,7*, Vincenzo Lagani, PhD1*, Jesper Tegnér, PhD1*, Jose A. Martinez-Climent, MD, PhD4, Xabier Agirre, PhD4*, Mikel Hernáez Arrazola, PhD3,5,8*, Felipe Prosper, MD, PhD4,5,9 and David Gomez-Cabrero, PhD1,10*

1Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal, Saudi Arabia
2Bioengineering Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal, Saudi Arabia
3Computational Biology Program CIMA-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra, IdISNA, Pamplona, Spain
4Hematology and Oncology Program, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
5Centro de Investigación Biomedica en Red de Cancer (CIBERONC), Madrid, Spain
6Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
7Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
8Center for Data Science and Artificial Intelligence Institute (DATAI), Universidad de Navarra, Pamplona, Spain
9Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain
10Translational Bioinformatics Unit, Navarrabiomed, Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain

Tim Robin Wagner1*, Niklas Kehl1*, Simon Steiger1*, Tamara Boschert1*, Michael Kilian, PhD2*, Kane A Foster, MSc3*, Hartmut Goldschmidt, MD4, Niels Weinhold, PhD4*, Steven A. Carr, PhD5*, Kwee Yong, MD, PhD3, Carsten Müller-Tidow, MD4*, Karsten Rippe, PhD1*, Marc S. Raab4*, Michael Platten, MD1*, Stefan B Eichmüller1* and Mirco Julian Friedrich, MD, PhD5*

1German Cancer Research Center (DKFZ), Heidelberg, Germany
2Brigham and Women's Hospital, Boston
3Cancer Institute, University College London, London, United Kingdom
4Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
5Broad Institute of MIT and Harvard, Cambridge, MA

James P. Roy, PhD1, Ee June Chua1*, Georgina S.F. Anderson, PhD1, Ben Uttenthal, MD PhD2,3* and Michael A. Chapman, PhD1,3,4,5

1MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom
2Cambridge University Hospitals, Cambridge, United Kingdom
3CRUK Cambridge Centre, Cambridge, United Kingdom
4Cambridge University Hospitals NHS Foundation, Cambridge, United Kingdom
5Department of Haematology, University of Cambridge, Cambridge, United Kingdom

Holly Lee, MD1, Sungwoo Ahn, PhD1*, Mansour Poorebrahim, PhD1*, David Jung, BSc1*, Sacha Benaoudia, PhD1*, Noémie Leblay, PhD1*, Francesco Maura, MD2, Lawrence H. Boise, PhD3, Paola Neri, MD, PhD1 and Nizar J. Bahlis, MD1

1Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
2University of Miami, Coral Gables, FL
3Emory University, Atlanta, GA

Dominic James Fowler-Shorten, MRes, BSc1*, Charlotte Hellmich, PhD, BSc, MBBChir1,2, Annalisa Altera, PhD1*, Rebecca S Maynard, MSc1*, Katherine Hampton, MSc, BSc1*, Matthew Markham, PhD1*, Alyssa Nicole Polski-Delve, MSc, BSc1*, Kristian Bowles, MBBS, PhD1,2 and Stuart A Rushworth, PhD3

1Norwich Medical School, University of East Anglia, Norwich, United Kingdom
2Norfolk and Norwich University Hospital, Norwich, United Kingdom
3The University of East Anglia, Norwich, United Kingdom

Jean-Baptiste Alberge, PhD1,2,3, Ankit K. Dutta, PhD1,2,3*, Andrea Poletti1,4,5*, Oliver Priebe3*, Tim H.H. Coorens, PhD3*, Elizabeth D. Lightbody, PhD1,2,3, Rosa Toenges, MD1,2,3*, Xavi Loinaz3*, Sofia Wallin1*, Andrew Dunford3*, Cody J. Boehner, BSc1*, Erica M. Horowitz, BA1*, Nang Kham Su, MSc1*, Hadley Barr, BSc1*, Laura Hevenor1*, Katherine Towle1*, Rashmika Beesam1*, Jenna D. Beckwith1*, Jacqueline Perry1*, David M. Cordas dos Santos, MD1,2,3*, Luca Bertamini, MD1*, Kirsten Kübler, MD3,6*, Carolina Terragna, PhD4*, Elena Zamagni, MD5,7*, Julian Hess3*, Romanos Sklavenitis-Pistofidis, MD1,2,3, Chip Stewart, PhD3*, Gad Getz, PhD2,3,8,9* and Irene Ghobrial, MD1,2,3

1Dana-Farber Cancer Institute, Boston, MA
2Harvard Medical School, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
5Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy
6Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
7Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
8Department of Pathology, Massachusetts General Hospital, Boston, MA
9Krantz Family Center for Cancer Research and Dept. of Pathology, Massachusetts General Hospital, Boston, MA

Romanos Sklavenitis-Pistofidis, MD1,2,3, Ting Wu, MS2*, Elizabeth D. Lightbody, PhD1,2,3, Yoshinobu Konishi, MD, PhD1,2,4, Mahshid Rahmat, PhD1,2,3*, Michael P. Agius, PhD1,2,5*, Junko Tsuji, PhD2*, Jean-Baptiste Alberge, PhD1,2,3, Michael Timonian, MD1,2,3*, Ankit K. Dutta, PhD1,2,3*, Michelle P. Aranha, PhD1,2,3*, Nayda Bidikian, MD1,2,3*, Hadley Barr, BSc3*, Nicholas J. Haradhvala, PhD2*, Moshe Sade-Feldman, PhD2*, Gad Getz, PhD1,2,6* and Irene Ghobrial, MD1,2,3

1Harvard Medical School, Boston, MA
2Broad Institute of MIT and Harvard, Cambridge, MA
3Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Brookline, MA
5Dana Farber Cancer Institute, Boston, MA
6Krantz Family Center for Cancer Research and Dept. of Pathology, Massachusetts General Hospital, Boston, MA

Xueping Wan, PhD1*, Yan Song, PhD1*, Ting Du, PhD1*, Arghya Ray, PhD1, Teng Fang, PhD1*, Minxing Wang, MS1*, Sindhu C Pillai, PhD1*, Md. Abu Musa, PhD1*, Kenneth Wen, BS1*, Dharminder Chauhan, PhD1* and Kenneth C. Anderson, MD2

1The Jerome Lipper Multiple Myeloma Center,Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2Dana-Farber Cancer Institute, The Jerome Lipper Multiple Myeloma Center, Boston, MA

Fengping Peng*, Zhaoyun Liu, PhD*, Fengjuan Jiang* and Rong Fu, MD

Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China

Joanna Blocka, MD1,2*, Seong Gu Heo, PhD3,4*, Shonali Midha, MD3*, Nathaniel G. Tadros5*, Steffen B. Kulp3*, Julia Frede, PhD3,4,6*, Marius Mathies3,4*, Nikhil C. Munshi, MD3, Andrew J. Yee, MD7* and Jens G. Lohr, MD, PhD3,4

1Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Dana-Farber Cancer Institute / Harvard Medical School, Boston, MA
2Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
3Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
4Broad Institute of MIT and Harvard, Cambridge, MA
5Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA
6German Cancer Consortium, Ludwig-Maximilian University of Munich, Munich, Germany
7Center for Multiple Myeloma, Mass General Cancer Center, Hematology / Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Marios Papadimitriou, MD1*, Sungwoo Ahn, PhD2*, Benjamin Diamond, MD1, Holly Lee, MD2, John McIntyre3*, Marietta Truger4*, Michael Durante, MD, PhD1*, Bachisio Ziccheddu1*, Ola Landgren1, Leo Rasche, MD5*, Nizar J. Bahlis, MD2, Paola Neri, MD, PhD2 and Francesco Maura, MD6

1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
2Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
3Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, AB, Canada
4MLL Munich Leukemia Laboratory, Munich, Germany
5Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany
6University of Miami, Coral Gables, FL

Mariko Ishibashi, PhD1*, Mika Sunakawa-Kii, MD2,3*, Yoichi Imai, MD PhD4*, Hiroki Yamaguchi, MD5, Rimpei Morita, MD, PhD3* and Hideto Tamura, MD, PhD6*

1Department of Microbiology and Immunology, Nippon Medical School, Bunkyo-Ku, Japan
2Department of Hematology, Nippon Medical School, Tokyo, Japan
3Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan
4Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
5Department of Hematology, Nippon Medical School Hospital, Tokyo, Japan
6Division of Diabetes, Endocrinology and Hematology, Department of Internal Medicine, Dokkyo Medical University Saitama Medical Center, Saitama, Japan

Thanh Mai Baumhardt1*, Vadim Sakk2*, Karin Soller2*, Miriam Kull, MD1*, Jan Kronke, MD3, Hartmut Geiger, Prof.2* and Medhanie Assmelash Mulaw, Jun.-Prof.4*

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Ulm University, Ulm, Germany
3Charité University Hospital, Berlin, Germany
4Unit for single-cell genomics, Medical faculty Ulm, Ulm, Germany

Xiaoyan Qu*, Yating Li*, Zhengxu Sun*, Wanting Ying*, Hailing Liu*, Sanmei Wang*, Miao Zhong*, Jianyong Li, MD and Lei Fan*

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Elizabeth D. Lightbody, PhD1,2,3, D. R. Mani, PhD2*, Hasmik Keshishian, PhD2*, Namrata Udeshi, PhD2*, Romanos Sklavenitis-Pistofidis, MD1,2,3, Ankit K. Dutta, PhD1,2,3*, Ting Wu, MS2*, Junko Tsuji, PhD2*, Habib El-Khoury, MD1,4*, Hadley Barr, BSc1*, Sarah Nersesian, PhD5*, Nang Kham Su, MSc1*, Cody J. Boehner, BSc1*, Michael P. Agius, PhD2,3,6*, Michelle P. Aranha, PhD1,2,3*, Laura Hevenor1*, Katherine Towle1*, Grace Fleming1*, Christian Cea-Curry, MSc1*, Daniel Heilpern-Mallory1*, Erica M. Horowitz, BA1*, Jacqueline F Perry1*, Maya Davis, BA1*, Kelly Walsh, PA-C7*, Annie Cowan, BA1,8*, John E. Ready, MD3,7*, Catherine R. Marinac, PhD1,3, Gad Getz, PhD2,3,9*, Michael Gillette, MD, PhD2*, Steven A. Carr, PhD2* and Irene Ghobrial, MD1,2,3

1Dana-Farber Cancer Institute, Boston, MA
2Broad Institute of MIT and Harvard, Cambridge, MA
3Harvard Medical School, Boston, MA
4University of Chicago Medical Center, Chicago, IL
5Dalhousie University, Halifax, NS, Canada
6Dana Farber Cancer Institute, Boston, MA
7Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA
8Mayo Clinic Alix School of Medicine, Rochester, MN
9Department of Pathology, Massachusetts General Hospital, Boston, MA

Yihao Zhan, MD1,2*, Hongling Peng, MD3*, David E. Mery, PhD4, Eric Siegel5*, Clyde Bailey, BS4*, Catherine Ma6*, Hongwei Xu, DDS4*, Daisy V. Alapat, MD7, Samer Al Hadidi, MD, MSc8, Carolina Schinke, MD4, Maurizio Zangari, MD4, Sharmilan Thanendrarajan, MD4, Frits van Rhee, MD, PhD4, Guido Tricot, MD4*, John D Shaughnessy, Jr, PhD4* and Fenghuang Zhan, MD4

1University of Arkansas for Medical, Little Rock, AR
2Department of Hematology, Second Xiang-ya Hospital, Central South University, Changsha, China
3Department of Hematology, The Second XIANGYA Hospital, Changsha, China
4Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
5Department of Biostatistics, University of Arkansas For Medical Sciences, Little Rock, AR
6Department of Internal Medicine, University of Arkansas for Medical, Little Rock, AR
7Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
8University of Arkansas for Medical Sciences, Little Rock, AR

Teng Fang, PhD1,2*, Yan Song, PhD1*, Ting Du, PhD1*, Arghya Ray, PhD1, Xueping Wan, PhD1*, Minxing Wang, MS1*, Sindhu C Pillai, PhD1*, Md. Abu Musa, PhD1*, Mu Hao, MD3*, Lugui Qiu2, Dharminder Chauhan, PhD1* and Kenneth C. Anderson, MD4

1The Jerome Lipper Multiple Myeloma Center,Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Dana-Farber Cancer Institute, The Jerome Lipper Multiple Myeloma Center, Boston, MA

Mark B. Meads, PhD1*, Xiaohong Zhao, MD, PhD1*, David R. Noyes, MS1*, Alexandra Achille1*, Praneeth Reddy Sudalagunta, PhD2*, Chaomei H. Zhang3*, Sonila Toska, MEd1*, Jongphil Kim, PhD4*, Samer Sansil5*, Sean J. Yoder, MS3*, Ariel Grajales-Cruz, MD5, Brandon Blue6, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP7, Melissa Alsina, MD8, Ariosto Siqueira Silva, PhD9*, Xiaofei Song, PhD4*, Rachid Baz, MD1 and Kenneth H. Shain, MD, PhD1

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3Molecular Genomics Core Facility, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
4Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
7Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Moffitt Cancer Center, Tampa, FL
9Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Yong Zhang, PhD1*, David G. Coffey, MD2, Elizabeth Hill, MD3*, Frank Cross Jr.4*, Reena Philip5*, Marc R. Theoret, MD5*, Ola Landgren6, Andrea C Baines, MD, PhD4* and Dickran Kazandjian, MD2

1Center for Drug Evaluation, US Food and Drug Administration, Silver Spring, MD
2Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
3Lymphoid Malignancies Branch, National Institutes of Health, Bethesda, MD
4Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
5Center for Drug Evaluation and Research, Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD
6Sylvester Comprehensive Cancer Center, Miami, FL

Bernice Matusow1*, Sadegh Saghafinia2*, Pei Pei Li2*, Amanda Kohler2*, Pan-Yu Chen, PhD3*, Christine Nichols2*, Parmveer Singh2*, Kerry Inokuchi2*, Jackie M. Walling, MCBhB PhD2 and Gideon Bollag, PhD2

1Opna Bio LLC, Hayward, CA
2Opna Bio LLC, South San Francisco, CA
3Opna Bio, LLC, South San Francisco, CA

Naser Ansari-Pour, PhD1*, Mohammad Kazeroun1*, Seyed Alireza Hasheminasab, PhD1*, Emma J Lyon2*, Bethan Hudson-Lund2*, Evie Fitzsimons2*, Gaurav Agarwal, MD3*, Kara-Louise Royle4*, Matthew W. Jenner5*, Martin F Kaiser, MD6, Karthik Ramasamy, MD, PhD7,8, Kwee Yong, MD, PhD2, Eileen M Boyle, MBChB, PhD2, Sarah Gooding, MD, PhD1,9,10*, Angela Hamblin, MD, PhD1,10* and Anjan Thakurta, PhD1

1Oxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom
2UCL Cancer Institute, University College London, London, United Kingdom
3Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cambridge
4Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
5University Hospital Southampton, Southampton, United Kingdom
6The Institute of Cancer Research, London, ENG, United Kingdom
7Oxford Translational Myeloma Centre, NDORMS University of Oxford, Department of Haematology, Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom
8Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom, Oxford, United Kingdom
9MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, ENG, United Kingdom
10Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

*signifies non-member of ASH